NIRx Medical Technologies, is excited to announce a strategic partnership with Dutch fNIRS pioneer Artinis Medical Systems.
The partnership is supported by healthcare investor Gilde Healthcare and unites two world-leading fNIRS innovators, creating a platform for the broader adoption of brain imaging technologies. NIRx will continue to operate under its own name, from its existing locations. NIRx will benefit from Artinis’ complementary product offerings. The shared expertise, integrated R&D, and increased scale will accelerate innovation and enhance the adoption of fNIRS in applied neuroscience. The joint commercial scale and aligned strategies will enable more researchers globally to access the most advanced fNIRS tools available. Leadership continuity is maintained, with Dr. Patrick Britz and Dr. Mylène Henry continuing to lead NIRx, and Dr. Willy Colier and Marianne Floor leading Artinis. Together, they are part of the new group’s leadership team.
Dr. Patrick Britz, CEO of NIRx: "Constant innovation has made functional near-infrared spectroscopy a rapidly growing and highly productive solution for neuroscience. Now, with the strong support of Gilde Healthcare, two highly skilled teams, NIRx and Artinis, are joining forces to accelerate these advancements. I am genuinely thrilled about the possibilities this partnership unlocks, fNIRS is just at its beginning."
Dr. Willy Colier, CEO of Artinis: "Roeland, my co-founder, and I are proud of Artinis' journey over the past 24 years. We have built a company known for its great products, fantastic people, and satisfied customers. Joining forces with NIRx is an exciting step that will enhance the value we provide to both our current and future customers. We look forward to this new phase as we leverage our combined scale and expertise, benefiting from the support of Gilde Healthcare."
This partnership positions NIRx to continue pushing the boundaries of fNIRS research, while preserving its core mission: enabling researchers to understand the human brain with greater clarity, flexibility, and accessibility. This is the beginning of a new era in brain imaging, and we look forward to it!